S

SK Life Science

Develops CNS and cancer therapies

Manager, Analytical Method Development - Radiopharmaceuticals

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeParamus, NJ, USAIn-person

About the Job

Requirements

  • A bachelor's degree in Chemistry, Biology, Life Sciences, or a related discipline is required.
  • At least 7 years of experience in the pharmaceutical or biotechnology industry is required.
  • At least 2–3 years of direct experience working with radiopharmaceutical products is required.
  • Strong hands-on experience in analytical method development and characterization is required.
  • Demonstrated experience transferring analytical methods to internal or external laboratories is required.

Responsibilities

  • Work with contract development and manufacturing organizations to develop, optimize, and qualify analytical methods supporting radiopharmaceutical drug substance and drug product development.
  • Design analytical methods for radioactive materials that account for decay, sensitivity, speed, and radiation safety considerations.
  • Apply analytical techniques including high-performance liquid chromatography, ultra-performance liquid chromatography, radio-high-performance liquid chromatography, gas chromatography, thin-layer chromatography, radio-thin-layer chromatography, spectroscopy, and wet chemistry methods.
  • Author and execute method qualification, validation, and verification protocols in accordance with International Council for Harmonisation and regulatory expectations.
  • Lead or support analytical method transfers to internal quality control laboratories, contract development and manufacturing organizations, and external testing sites.
  • Troubleshoot method performance issues during transfer and routine testing to ensure robustness and reproducibility.
  • Support testing of precursors and radiolabeled finished drug products, including identity, purity, potency, and impurity profiling.
  • Collaborate with Radiation Safety Officers to ensure compliant handling and testing of radioactive materials.
  • Develop rapid, fit-for-purpose methods for short half-life products and just-in-time manufacturing models.
  • Prepare and review technical reports, method standard operating procedures, validation reports, and specifications.
  • Contribute analytical-method content to Chemistry, Manufacturing, and Controls sections of regulatory submissions, including Investigational New Drug applications, Clinical Trial Applications, Investigational Medicinal Product Dossiers, and New Drug Applications/Biologics License Applications.
  • Support regulatory interactions, audits, and inspections by providing analytical expertise and documentation.
  • Partner with Chemistry, Manufacturing, and Controls, Process Development, Manufacturing, Quality, and Clinical teams to align analytical strategies with development timelines.
  • Support investigations of out-of-specification and out-of-trend results and implement corrective actions as needed.
  • Drive continuous improvement in analytical efficiency, data integrity, and method lifecycle management.

Desired Qualifications

  • An advanced degree (Master’s or Ph.D.) in Chemistry, Pharmaceutical Sciences, or a related field is preferred.
  • Experience supporting regulatory submissions involving radiopharmaceuticals is preferred.
  • Familiarity with good manufacturing practice environments and data integrity requirements, such as ALCOA+, is preferred.

About the Company

SK Life Science

Develops CNS and cancer therapies

SK Life Science is a U.S. subsidiary focused on developing medicines for central nervous system (CNS) disorders and cancer. Its work centers on researching and bringing pharmaceutical treatments to market that address neurological diseases and oncology, leveraging the broader SK Group’s resources and expertise. The company’s products work by targeting disease mechanisms in CNS conditions or cancer, delivered through conventional pharmaceutical formulations developed through its science-driven pipeline (as part of SK Biopharmaceuticals). What sets SK Life Science apart from competitors is its backing by SK Group and SK Biopharmaceuticals, enabling strong research, development, and global scale, as well as a stated commitment to real patient impact in CNS and oncology. The company aims to transform lives by delivering meaningful treatments that improve outcomes for patients with CNS disorders and cancer.

Company size
Not listed
Company stage
Not listed
Total funding
Not listed
Headquarters
Paramus, NJ
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at SK Life Science

See more jobs